Font Size: a A A
Keyword [Acquired drug resistance]
Result: 21 - 39 | Page: 2 of 2
21. Study On Acquired Drug Resistance Of Human Cervical Cancer Hela Cells Doxorubicin Based On Transcriptome Sequencing
22. Study Of The Molecular Mechanism Of 5-FU-acquired Drug Resistance Of Colon Cancer HCT-8 Cells Based On Whole Transcriptome Sequencing
23. Blockade Of Cell Surface GRP78 Inhibits The Growth And Metastasis Of Erlotinib Resistant Tongue Squamous Cancer
24. Mechanism Of SIRT1 In Bortezomib-induced Drug Resistance In Multiple Myeloma
25. Establishment Of The Third Generation EGFR-TKI AZD9291 Drug-resistance NSCLC Cell Lines In Vitro
26. Metabolomics Of Active Aldehyde In Lung Cancer Cells With EGFR-TKI Acquired Drug Resistance
27. Study On The Natural Polymorphisms Of Pol Gene And Acquired Drug Resistance Mutations After Long-Term Antiretroviral Treatment Of CRF01_AE HIV-1 Strain In Liaoning Province
28. Observation On The Efficacy Of Three Treatment Options For T790M Negative Advanced NSCLC Patients After First Generation EGFR-TKIs Resistance
29. Development of the proteolytic oxygen-18 labeling method and application to acquired drug resistance
30. The Role of Darpp-32 and t-Darpp in Breast Cancer Tumorigenesis and the Development of Acquired Drug Resistance
31. Study On The Role Of MiR-873 In The Reversing Effect Of Intercalated Treatment In Lung Cancer Patients With Acquired Resistance To EGFR Tyrosine Kinase Inhibitors
32. MiR-206 Involved In Gefitinib Acquired Drug-resistance In Non-small Cell Lung Cancer Patients Through Modulating IL-6 Expression
33. IGFBP7 Involves In Acquired Resistance To Osimertinib In Non-small Cell Lung Cancer
34. Investigation On The Enhanced Inhibitory Effect Of Cardamonin And Its Mechanism On Paclitaxel-Resistant Ovarian Cancer Cells
35. B7-H3 As A Predictor Of Clinical Outcome In Lung Adenocarcinoma Patients Treated With EGFR Tyrosine Kinase Inhibitors
36. Research On The Acquired Drug Resistance To Cancer Kinase Inhibitors For Cancer Treatment Based On Transcriptomics Data
37. Analysis Of Clinical Characteristics Of Advanced Lung Adenocarcinoma Patients With Acquired T790M Mutation In The Epidermal Growth Factor Receptor
38. Correlation Between Expression Of PLOD2 And Acquired Resistance Of The First Generation Of EGFR-TKI In Advanced Lung Adenocarcinoma
39. The Effect Of TGF-?1 On Acquired Resistance To EGFR-TKI In NSCLC Cell NCI-H1975
  <<First  <Prev  Next>  Last>>  Jump to